
Keywords: AGRP; Agouti-related peptide; BBB; Blood-brain barrier; CART; Cocaine- and amphetamine-regulated transcript; CAD; Cardiovascular disease; FNDC; Fibronectin type III domain-containing protein; HAART; Highly active antiretroviral therapy; HIV; Human immun